HBS1L
Basic information
Region (hg38): 6:134960378-135103056
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HBS1L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 22 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 2 | 2 |
Variants in HBS1L
This is a list of pathogenic ClinVar variants found in the HBS1L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-134966324-A-C | Benign (Dec 31, 2019) | |||
6-134966451-C-T | not specified | Uncertain significance (Oct 14, 2023) | ||
6-134978710-T-C | not specified | Uncertain significance (Oct 17, 2023) | ||
6-134978767-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
6-134978779-C-T | not specified | Uncertain significance (May 24, 2023) | ||
6-134979218-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
6-134979224-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
6-134982499-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
6-134985353-C-G | not specified | Uncertain significance (Nov 08, 2022) | ||
6-134985379-T-C | not specified | Uncertain significance (Apr 15, 2024) | ||
6-134986771-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
6-134987715-C-T | not specified | Uncertain significance (Nov 12, 2021) | ||
6-134987790-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
6-134993774-A-T | not specified | Uncertain significance (Dec 15, 2023) | ||
6-134997435-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
6-134997577-C-T | not specified | Uncertain significance (May 24, 2024) | ||
6-134997600-A-G | not specified | Uncertain significance (Feb 06, 2023) | ||
6-135002758-T-C | not specified | Uncertain significance (Mar 28, 2024) | ||
6-135002789-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
6-135002821-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
6-135002823-C-G | Benign (May 16, 2018) | |||
6-135002834-C-T | Benign (Jun 28, 2018) | |||
6-135002837-G-C | not specified | Uncertain significance (Oct 14, 2023) | ||
6-135039662-T-G | not specified | Uncertain significance (Apr 18, 2023) | ||
6-135042039-T-C | not specified | Uncertain significance (Jan 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HBS1L | protein_coding | protein_coding | ENST00000367837 | 18 | 142679 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.86e-7 | 1.00 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.890 | 316 | 364 | 0.869 | 0.0000190 | 4459 |
Missense in Polyphen | 129 | 166.78 | 0.77346 | 2088 | ||
Synonymous | 0.629 | 123 | 132 | 0.930 | 0.00000754 | 1313 |
Loss of Function | 3.17 | 18 | 39.5 | 0.456 | 0.00000222 | 466 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000400 | 0.000394 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000165 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000267 | 0.000264 |
Middle Eastern | 0.000165 | 0.000163 |
South Asian | 0.000101 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Legionellosis - Homo sapiens (human);mRNA surveillance pathway - Homo sapiens (human);Metabolism of RNA;mRNA decay by 3, to 5, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.252
Intolerance Scores
- loftool
- 0.450
- rvis_EVS
- 1.23
- rvis_percentile_EVS
- 93.25
Haploinsufficiency Scores
- pHI
- 0.419
- hipred
- N
- hipred_score
- 0.426
- ghis
- 0.568
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.859
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hbs1l
- Phenotype
- homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; vision/eye phenotype; hematopoietic system phenotype; reproductive system phenotype; pigmentation phenotype;
Gene ontology
- Biological process
- translation;translational elongation;signal transduction;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay
- Cellular component
- cytosol;membrane;extracellular exosome
- Molecular function
- translation elongation factor activity;GTPase activity;GTP binding